DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ dropped 0.55% to $1.82 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.16% to 19,280.79 and Dow Jones Industrial Average falling 0.36% to 42,392.27.
Inovio Pharmaceuticals Inc. closed $12.93 below its 52-week high ($14.75), which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.41% to $144.02, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.30% to $26.61.
Trading volume (1.3 M) eclipsed its 50-day average volume of 801,506.
Data source: Dow Jones Market Data, FactSet. Data compiled January 2, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 02, 2025 17:33 ET (22:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。